TDS PDF

↑
St CLSI M23-2018

Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters. Original standard CLSI M23-2018 in PDF full version. Additional info + preview on request

Document status: Replaced by St CLSI M23-Ed6-2023

€35
St CLSI M23-Ed6-2023

Development of In Vitro Susceptibility Test Methods, Breakpoints, and Quality Control Parameters. Original standard CLSI M23-Ed6-2023 in PDF full version. Additional info + preview on request

Document status: Active

€35
St CLSI M23S-Ed2-2024

Procedure for Optimizing Disk Contents (Potencies) for Disk Diffusion Testing of Antimicrobial Agents Using Harmonized CLSI and EUCAST Criteria. Original document CLSI M23S-Ed2-2024 in PDF full version. Additional info + preview on request

Document status: Active

€35
St CLSI M23S2-Ed2-2024

Process to Submit Disk Content (Potency) Data for Joint CLSI-EUCAST Working Group Review and Approval. Original document CLSI M23S2-Ed2-2024 in PDF full version. Additional info + preview on request

Document status: Active

€35
St CLSI M23S3-Ed1-2023

Procedure for Confirming the Acceptability of Mueller-Hinton Agar Sources for Subsequent Use in Studies by CLSI, EUCAST, or both to Establish Disk Diffusion Quality Control Ranges. Original document CLSI M23S3-Ed1-2023 in PDF full version. Additional info + preview on request

Document status: Active

€35
St CLSI M24-2018

Susceptibility Testing of Mycobacteria, Nocardia spp., and Other Aerobic Actinomycetes. Original standard CLSI M24-2018 in PDF full version. Additional info + preview on request

Document status: Active

€35
↑